176 related articles for article (PubMed ID: 19642024)
21. Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours.
Scott N; Millward E; Cartwright EJ; Preston SR; Coletta PL
J Clin Pathol; 2004 Feb; 57(2):189-92. PubMed ID: 14747448
[TBL] [Abstract][Full Text] [Related]
22. Spinal Functions of B-Type Natriuretic Peptide, Gastrin-Releasing Peptide, and Their Cognate Receptors for Regulating Itch in Mice.
Kiguchi N; Sukhtankar DD; Ding H; Tanaka K; Kishioka S; Peters CM; Ko MC
J Pharmacol Exp Ther; 2016 Mar; 356(3):596-603. PubMed ID: 26669425
[TBL] [Abstract][Full Text] [Related]
23. Gastrin-releasing peptide as a molecular target for inflammatory diseases: an update.
Petronilho F; Danielski LG; Roesler R; Schwartsmann G; Dal-Pizzol F
Inflamm Allergy Drug Targets; 2013 Jun; 12(3):172-7. PubMed ID: 23621446
[TBL] [Abstract][Full Text] [Related]
24. Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans.
Carroll RE; Matkowskyj KA; Chakrabarti S; McDonald TJ; Benya RV
Am J Physiol; 1999 Mar; 276(3):G655-65. PubMed ID: 10070042
[TBL] [Abstract][Full Text] [Related]
25. Docosahexaenoic Acid Helps to Lessen Extinction Memory in Rats.
Hashimoto M; Hossain S; Katakura M; Mamun AA; Shido O
Molecules; 2018 Feb; 23(2):. PubMed ID: 29463009
[No Abstract] [Full Text] [Related]
26. Anti-EGFR therapy combined with neuromedin B receptor blockade induces the death of DAOY medulloblastoma cells.
Jaeger M; Nör C; de Farias CB; Abujamra AL; Schwartsmann G; Brunetto AL; Roesler R
Childs Nerv Syst; 2013 Dec; 29(12):2145-50. PubMed ID: 24092425
[TBL] [Abstract][Full Text] [Related]
27. Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disorders.
Roesler R; Henriques JA; Schwartsmann G
CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):197-204. PubMed ID: 16611092
[TBL] [Abstract][Full Text] [Related]
28. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
Nakagawa T; Hocart SJ; Schumann M; Tapia JA; Mantey SA; Coy DH; Tokita K; Katsuno T; Jensen RT
Biochem Pharmacol; 2005 Feb; 69(4):579-93. PubMed ID: 15670577
[TBL] [Abstract][Full Text] [Related]
29. Gastrin-releasing peptide and its receptor increase arthritis fibroblast-like synoviocytes invasiveness through activating the PI3K/AKT pathway.
Clarimundo VS; Farinon M; Pedó RT; Teixeira VON; Nör C; Gulko PS; Xavier RM; de Oliveira PG
Peptides; 2017 Sep; 95():57-61. PubMed ID: 28733141
[TBL] [Abstract][Full Text] [Related]
30. Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma.
Pansky A; DE Weerth A; Fasler-Kan E; Boulay JL; Schulz M; Ketterer S; Selck C; Beglinger C; VON Schrenck T; Hildebrand P
J Am Soc Nephrol; 2000 Aug; 11(8):1409-1418. PubMed ID: 10906154
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix.
Chatzistamou I; Schally AV; Szepeshazi K; Groot K; Hebert F; Arencibia JM
Cancer Lett; 2001 Sep; 171(1):37-45. PubMed ID: 11485826
[TBL] [Abstract][Full Text] [Related]
32. Expression of GRP and its receptor is associated with improved survival in patients with colon cancer.
Rivera CA; Ahlberg NC; Taglia L; Kumar M; Blunier A; Benya RV
Clin Exp Metastasis; 2009; 26(7):663-71. PubMed ID: 19430935
[TBL] [Abstract][Full Text] [Related]
33. Characterization of NMB, GRP and their receptors (BRS3, NMBR and GRPR) in chickens.
Mo C; Huang L; Cui L; Lv C; Lin D; Song L; Zhu G; Li J; Wang Y
J Mol Endocrinol; 2017 Jul; 59(1):61-79. PubMed ID: 28500250
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II.
Kahán Z; Sun B; Schally AV; Arencibia JM; Cai RZ; Groot K; Halmos G
Cancer; 2000 Mar; 88(6):1384-92. PubMed ID: 10717621
[TBL] [Abstract][Full Text] [Related]
35. Bombesin induces angiogenesis and neuroblastoma growth.
Kang J; Ishola TA; Baregamian N; Mourot JM; Rychahou PG; Evers BM; Chung DH
Cancer Lett; 2007 Aug; 253(2):273-81. PubMed ID: 17383815
[TBL] [Abstract][Full Text] [Related]
36. Eicosapentaenoic acid (EPA) increases cell viability and expression of neurotrophin receptors in retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cells.
Kou W; Luchtman D; Song C
Eur J Nutr; 2008 Mar; 47(2):104-13. PubMed ID: 18360785
[TBL] [Abstract][Full Text] [Related]
37. Distribution of the pig gastrin-releasing peptide receptor and the effect of GRP on porcine Leydig cells.
Ma Z; Zhang Y; Su J; Li X; Yang S; Qiao W; Suo C; Lei Z
Peptides; 2018 Jan; 99():142-152. PubMed ID: 28966141
[TBL] [Abstract][Full Text] [Related]
38. Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophils.
Czepielewski RS; Porto BN; Rizzo LB; Roesler R; Abujamra AL; Pinto LG; Schwartsmann G; Cunha Fde Q; Bonorino C
Proc Natl Acad Sci U S A; 2012 Jan; 109(2):547-52. PubMed ID: 22203955
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of gastrin-releasing peptide receptor (GRPR) and possible regulation by estrogen receptor βcx in human prostate carcinoma.
Nagasaki S; Nakamura Y; Maekawa T; Akahira J; Miki Y; Suzuki T; Ishidoya S; Arai Y; Sasano H
Neoplasma; 2012; 59(2):224-32. PubMed ID: 22248281
[TBL] [Abstract][Full Text] [Related]
40. Regulation of HER expression and transactivation in human prostate cancer cells by a targeted cytotoxic bombesin analog (AN-215) and a bombesin antagonist (RC-3095).
Sotomayor S; Muñoz-Moreno L; Carmena MJ; Schally AV; Sánchez-Chapado M; Prieto JC; Bajo AM
Int J Cancer; 2010 Oct; 127(8):1813-22. PubMed ID: 20099275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
